Researchers identify a treatment for a rare bone loss disorder that might also lead to help for aging brittle bones
A possible ‘first-line’ treatment for a rare bone loss disease has been identified by a research team led by Tohoku University in Japan. The research findings, published in the journal Molecular Cell, could also provide insight into treating age-related osteoporosis.
Hajdu-Cheney syndrome is a rare genetic disease that leads to severe osteoporosis and developmental defects, including the reabsorption of bones in the hands and feet. The disease is associated with mutations in a particular gene, called NOTCH2, which codes for proteins involved with bone maintenance. The NOTCH2 proteins usually help balance destruction and construction essential for bone maintenance and repair. Mutations associated with Hajdu-Cheney syndrome upset that balance, but the exact mechanisms causing bone resorption have not been well understood.
Now, through a series of detailed tests, molecular biologist Hiroyuki Inuzuka and his colleagues have worked out the specific molecular pathway that results in Hajdu-Cheney syndrome.
They found that this particular NOTCH2 mutation does not maintain normal NOTCH2 protein abundance, with the help of another protein, called FBW7. To discover this, the researchers knocked out the gene for Fbw7 in the bones of mice. Without the gene and resulting protein, the mice had severe osteoporosis, much like people with Hajdu-Cheney syndrome — indicating that FBW7 is the primary regulator of this system.
They further determined that in humans with Hajdu-Cheney syndrome, the FBW7 protein was unable to bind to NOTCH2 proteins because the binding spot is missing in osteoclasts. This mutation allows the osteoclasts to over-operate, breaking down too much bone tissue.
The researchers were able to reverse bone loss in the knock-out mice with the elevated NOTCH2 by giving them a medication that blocks osteoclast formation. They tried several different treatments, including a chemical compound called DAPT that was particularly effective. DAPT has been shown to help with osteoarthritis by inhibiting function of NOTCH proteins in other studies. Using DAPT as well as Zoledronic acid, a common medication for osteoporosis, “may become a first-line treatment for Hadju-Cheney syndrome,” the researchers conclude in their study.
“By clearly identifying the relationship between FBW7 and NOTCH2 proteins, we have identified potential therapeutic targets for patients with rare bone diseases as well as much more widespread age-related osteoporosis,” said Inuzuka.
Learn more: Reversing severe bone loss
The Latest on: Bone loss
[google_news title=”” keyword=”bone loss” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Bone loss
- Can Rheumatoid Arthritis Treatment Reduce Bone Density? Know From A Doctoron February 21, 2024 at 10:56 pm
"Bone density measurement plays a crucial role in the management of RA. Monitoring it enables doctors to assess the extent of bone loss and determine appropriate interventions to minimise fracture ...
- Cancer-Treatment-Induced Bone Loss, Part 1on February 17, 2024 at 4:00 pm
Evidence also suggests that preventive CTIBL therapy may halt bone loss.  These patients should therefore be considered for CTIBL treatment and, perhaps, prophylaxis therapy if multiple risk ...
- Unlocking the Secrets of Bone Loss in Zero Gravityon February 16, 2024 at 10:46 pm
Stem cell research carried into Friday as the Expedition 70 crew members worked to wrap up an experiment that began earlier in the week. As science continued aboard the International Space Station, a ...
- Women Over 50: Best Diets for Weight Losson February 16, 2024 at 1:07 pm
Weight loss for women over 50 isn’t easy. These are the best diets for women to lose weight, improve brain health and retain bone density as they get older.
- Men With OSA May Experience Early Bone Losson February 15, 2024 at 4:00 pm
In the men with OSA studied, negative changes in the osteogenesis process were already present during middle age. Men with obstructive sleep apnea (OSA) have lower volumetric bone mineral density ...
- How to Reduce Your Risk of Breaking a Bone Due to Osteoporosison February 14, 2024 at 4:00 pm
After menopause, bone loss continues but at a slower rate. However, around age 65-70 everyone loses bone mass at about the same rate. You can prevent osteoporosis, especially if you begin early.
- To fight bone loss, FDA approves vibration belt shown to help post-menopausal womenon February 4, 2024 at 4:52 am
Post-menopausal women may soon have a new weapon in the fight against bone loss. The U.S. Food and Drug Administration (FDA) recently granted clearance for a vibration belt known as Osteoboost.
- To fight bone loss, FDA approves vibration belt shown to help post-menopausal womenon February 3, 2024 at 4:00 pm
Post-menopausal women may soon have a new weapon in the fight against bone loss. The U.S. Food and Drug Administration (FDA) recently granted clearance for a vibration belt known as Osteoboost. The ...
- What You Need to Know About the Health Benefits of Collagenon January 28, 2024 at 4:00 pm
It may help improve skin health, relieve joint pain, and prevent bone loss, among other things. Collagen is a protein. Your body makes it, and it’s important for healthy joints, skin ...
via Bing News